Encompass Health Corp
EHC104.500USD
-1.450-1.37%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
10.51BMarktkapitalisierung
19.46KGV TTM
mehr Informationen über Encompass Health Corp Unternehmen
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Encompass Health Corp Informationen
BörsenkürzelEHC
Name des UnternehmensEncompass Health Corp
IPO-datumSep 24, 1986
CEOTarr (Mark J)
Anzahl der mitarbeiter23564
WertpapierartOrdinary Share
GeschäftsjahresendeSep 24
Addresse9001 Liberty Pkwy
StadtBIRMINGHAM
BörseNASDAQ OMX NASDAQ Basic NYSE
LandUnited States of America
Postleitzahl35242-7509
Telefon12059677116
Websitehttps://www.encompasshealth.com/
BörsenkürzelEHC
IPO-datumSep 24, 1986
CEOTarr (Mark J)
Führungskräfte von Encompass Health Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Douglas E. (Doug) Coltharp
Mr. Douglas E. (Doug) Coltharp
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
251.19K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3.71%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.75K
+0.15%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.22K
+0.16%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-5.13%
Mr. Gregory D. (Greg) Carmichael
Mr. Gregory D. (Greg) Carmichael
Independent Director
Independent Director
18.63K
+0.12%
Mr. Terrance Williams
Mr. Terrance Williams
Independent Director
Independent Director
15.14K
+0.15%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Independent Director
Independent Director
15.09K
+2.06%
Dr. Elissa Joy Charbonneau
Dr. Elissa Joy Charbonneau
Chief Medical Officer
Chief Medical Officer
11.96K
-26.35%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Douglas E. (Doug) Coltharp
Mr. Douglas E. (Doug) Coltharp
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
251.19K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3.71%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.75K
+0.15%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.22K
+0.16%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-5.13%
Umsatzaufteilung
Währung: USDAktualisiert: Mon, Oct 6
Währung: USDAktualisiert: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medicare
939.70M
64.46%
Medicare Advantage
246.00M
16.88%
Managed Care
163.00M
11.18%
Medicaid
45.20M
3.10%
Other Income Source
41.30M
2.83%
Andere
22.50M
1.54%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Medicare
939.70M
64.46%
Medicare Advantage
246.00M
16.88%
Managed Care
163.00M
11.18%
Medicaid
45.20M
3.10%
Other Income Source
41.30M
2.83%
Andere
22.50M
1.54%
Aktionärsstatistik
Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Andere
70.16%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
10.15%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Andere
70.16%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.19%
Investment Advisor/Hedge Fund
34.64%
Hedge Fund
6.41%
Bank and Trust
2.15%
Pension Fund
2.06%
Research Firm
1.80%
Individual Investor
1.50%
Sovereign Wealth Fund
1.24%
Insurance Company
0.13%
Andere
0.88%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
1064
98.33M
97.73%
-1.53M
2025Q3
1072
97.93M
99.39%
+709.65K
2025Q2
1033
97.25M
101.81%
-1.92M
2025Q1
979
99.67M
102.60%
-3.66M
2024Q4
945
99.00M
102.85%
-881.71K
2024Q3
884
99.36M
106.17%
-310.63K
2024Q2
889
99.51M
109.15%
-995.73K
2024Q1
858
100.71M
112.68%
-12.13M
2023Q4
852
101.16M
110.27%
+2.80M
2023Q3
865
97.95M
111.77%
+322.90K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
10.22M
10.15%
-140.47K
-1.36%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.48M
8.43%
-4.83K
-0.06%
Sep 30, 2025
Invesco Advisers, Inc.
4.48M
4.45%
-276.20K
-5.81%
Sep 30, 2025
T. Rowe Price Associates, Inc.
3.77M
3.74%
+2.44M
+184.81%
Sep 30, 2025
State Street Investment Management (US)
3.08M
3.06%
-24.31K
-0.78%
Sep 30, 2025
Wellington Management Company, LLP
2.78M
2.76%
-744.16K
-21.11%
Sep 30, 2025
AllianceBernstein L.P.
2.52M
2.5%
+476.56K
+23.37%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.14M
2.13%
-34.67K
-1.59%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
2.06M
2.05%
+238.21K
+13.06%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.81M
1.8%
+34.70K
+1.96%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
PGIM Jennison Focused Mid-Cap ETF
3.17%
Inspire Growth ETF
2.88%
Opus Small Cap Value ETF
2.23%
State Street SPDR S&P Health Care Services ETF
1.86%
iShares U.S. Healthcare Providers ETF
1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
1.74%
Bahl & Gaynor Dividend ETF
1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
JPMorgan Active Small Cap Value ETF
1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
1.07%
Mehr Anzeigen
PGIM Jennison Focused Mid-Cap ETF
Anteil3.17%
Inspire Growth ETF
Anteil2.88%
Opus Small Cap Value ETF
Anteil2.23%
State Street SPDR S&P Health Care Services ETF
Anteil1.86%
iShares U.S. Healthcare Providers ETF
Anteil1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
Anteil1.74%
Bahl & Gaynor Dividend ETF
Anteil1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil1.18%
JPMorgan Active Small Cap Value ETF
Anteil1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Anteil1.07%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
334.60M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Oct 23, 2025
EHC.NB Final Cash Dividend of gross USD 0.19 paid on Jan 15, 2026 going ex on Jan 02, 2026
Jan 02, 2026
Jan 15, 2026
Jan 02, 2026
Jul 24, 2025
EHC.NB Interim Cash Dividend of gross USD 0.19 paid on Oct 15, 2025 going ex on Oct 01, 2025
Oct 01, 2025
Oct 15, 2025
Oct 01, 2025
May 01, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 15, 2025 going ex on Jul 01, 2025
Jul 01, 2025
Jul 15, 2025
Jul 01, 2025
Feb 20, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 15, 2025 going ex on Apr 01, 2025
Apr 01, 2025
Apr 15, 2025
Apr 01, 2025
Oct 17, 2024
EHC.NB Final Cash Dividend of gross USD 0.17 paid on Jan 15, 2025 going ex on Jan 02, 2025
Jan 02, 2025
Jan 15, 2025
Jan 02, 2025
Jul 24, 2024
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 15, 2024 going ex on Oct 01, 2024
Oct 01, 2024
Oct 15, 2024
Oct 01, 2024
May 02, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Jul 15, 2024 going ex on Jul 01, 2024
Jul 01, 2024
Jul 15, 2024
Jul 01, 2024
Feb 28, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Apr 15, 2024 going ex on Mar 28, 2024
Apr 01, 2024
Apr 15, 2024
Mar 28, 2024
Oct 19, 2023
EHC.NB Final Cash Dividend of gross USD 0.15 paid on Jan 16, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 16, 2024
Dec 29, 2023
Jul 20, 2023
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Oct 16, 2023 going ex on Sep 29, 2023
Oct 02, 2023
Oct 16, 2023
Sep 29, 2023
Mehr Anzeigen
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Encompass Health Corp?
Die fünf größten Anteilseigner von Encompass Health Corp sind:
The Vanguard Group, Inc. hält 10.22M Aktien, was 10.15% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 8.48M Aktien, was 8.43% der Gesamtaktien entspricht.
Invesco Advisers, Inc. hält 4.48M Aktien, was 4.45% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 3.77M Aktien, was 3.74% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 3.08M Aktien, was 3.06% der Gesamtaktien entspricht.
The Vanguard Group, Inc. hält 10.22M Aktien, was 10.15% der Gesamtaktien entspricht.
BlackRock Institutional Trust Company, N.A. hält 8.48M Aktien, was 8.43% der Gesamtaktien entspricht.
Invesco Advisers, Inc. hält 4.48M Aktien, was 4.45% der Gesamtaktien entspricht.
T. Rowe Price Associates, Inc. hält 3.77M Aktien, was 3.74% der Gesamtaktien entspricht.
State Street Investment Management (US) hält 3.08M Aktien, was 3.06% der Gesamtaktien entspricht.
Was sind die drei wichtigsten Anteilseigner-Typen von Encompass Health Corp?
Die drei wichtigsten Anteilseigner-Typen von Encompass Health Corp sind:
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
Invesco Advisers, Inc.
Wie viele Institutionen halten Anteile an Encompass Health Corp (EHC)?
Mit Stand vom 2025Q4 halten 1064 Institutionen Anteile an Encompass Health Corp, mit einem Gesamtmarktwert von etwa 98.33M, was 97.73% der Gesamtanteile entspricht. Im Vergleich zum 2025Q3 ist der institutionelle Aktienbesitz um -1.67% gestiegen.
Was ist die größte Einnahmequelle von Encompass Health Corp?
Am FY2025Q2 erzielte das Geschäft mit Medicare für Encompass Health Corp den höchsten Umsatz in Höhe von 939.70M, was 64.46% des Gesamtumsatzes entspricht.
